TRT at a primary care clinic: what the science says vs. TikTok

What's this video probably claiming?

Based on the caption referencing "Mend Primary Care/Clinic" and the TRT category tag, this video likely walks viewers through what a testosterone replacement therapy consultation or visit looks like at a primary care clinic. Creators in this space typically claim that getting TRT is straightforward, that primary care is a viable route for diagnosis and treatment, and that testosterone optimization improves energy, libido, body composition, and mood. Some creators in this category also push the idea that "normal" lab ranges are too conservative and that men with low-normal testosterone deserve treatment. Whether @titi2022_1 is a patient documenting their journey or a provider marketing services, the framing almost certainly centers on TRT as accessible and beneficial. That framing is partly right, but the details matter enormously, and TikTok tends to strip those details out.

What does the science actually show?

The clinical evidence for TRT in men with confirmed hypogonadism, meaning serum testosterone consistently below 300 ng/dL with symptoms, is actually reasonably solid. The AUA 2018 guidelines and the 2023 testosterone trial data support improvements in sexual function, bone density, and lean mass. Bhasin et al. (2018, New England Journal of Medicine), the landmark testosterone trials, showed modest but real improvements in sexual desire and erectile function in men with low testosterone. Body composition improvements, specifically reduced fat mass and increased lean mass, were real but modest, around 1.5 to 3 kg differences over 12 months. What the science does not support is treating men with low-normal testosterone (300 to 400 ng/dL) who have vague fatigue as if they have a clear hormone deficiency. The 2020 Endocrine Society guidelines explicitly require two fasting morning testosterone measurements before diagnosis, something that gets skipped constantly in the optimization clinic model.

Where does the social media noise diverge from clinical reality?

The TRT TikTok ecosystem has a consistent problem: it collapses the distinction between treating a diagnosed medical condition and "optimizing" hormones in men who are technically within normal range. Clinics like the one referenced in this caption often operate in that grey zone, marketing to men with normal-ish testosterone who feel tired or have low libido, conditions with dozens of causes that have nothing to do with testosterone. The real divergence shows up in cardiovascular risk framing. Many TRT content creators downplay hematocrit elevation and erythrocytosis risk, which affects roughly 18 to 25 percent of men on injectable testosterone per Coviello et al. (2008, Journal of Clinical Endocrinology and Metabolism). Polycythemia increases clotting risk. That is not a footnote. Social media TRT content also routinely ignores the suppression of endogenous testosterone production and the fertility implications, which are significant, especially for men under 40.

What should you actually know?

If a primary care clinic is offering TRT, the quality of that care depends entirely on whether they are doing the diagnostic work correctly. That means two morning fasting testosterone draws, LH and FSH levels to distinguish primary from secondary hypogonadism, a hematocrit baseline, a PSA if you are over 40, and a real conversation about fertility if you want children. Testosterone cypionate at standard clinical doses (typically 100 to 200 mg per week intramuscularly, though formulations vary) requires monitoring every 3 to 6 months, not just an initial lab and a refill. The FDA-approved indication is hypogonadism, not wellness optimization. If a clinic is prescribing based on symptoms alone without rigorous lab confirmation, that is a red flag regardless of how good the TikTok content looks. Primary care can absolutely be an appropriate setting for TRT, but the standard of care does not change based on the clinic's branding.